Skip to main content

Most of patients with localized prostate cancer will be treated in the future? | Opinion: No.

Publication ,  Journal Article
Schulman, AA; Polascik, TJ
Published in: Int Braz J Urol
2017

Duke Scholars

Published In

Int Braz J Urol

DOI

EISSN

1677-6119

Publication Date

2017

Volume

43

Issue

4

Start / End Page

584 / 587

Location

Brazil

Related Subject Headings

  • Urology & Nephrology
  • Risk Assessment
  • Prostatic Neoplasms
  • Prostate-Specific Antigen
  • Prognosis
  • Male
  • Magnetic Resonance Imaging
  • Humans
  • Forecasting
  • Early Detection of Cancer
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Schulman, A. A., & Polascik, T. J. (2017). Most of patients with localized prostate cancer will be treated in the future? | Opinion: No. Int Braz J Urol, 43(4), 584–587. https://doi.org/10.1590/S1677-5538.IBJU.2017.04.03
Schulman, Ariel A., and Thomas J. Polascik. “Most of patients with localized prostate cancer will be treated in the future? | Opinion: No.Int Braz J Urol 43, no. 4 (2017): 584–87. https://doi.org/10.1590/S1677-5538.IBJU.2017.04.03.
Schulman AA, Polascik TJ. Most of patients with localized prostate cancer will be treated in the future? | Opinion: No. Int Braz J Urol. 2017;43(4):584–7.
Schulman, Ariel A., and Thomas J. Polascik. “Most of patients with localized prostate cancer will be treated in the future? | Opinion: No.Int Braz J Urol, vol. 43, no. 4, 2017, pp. 584–87. Pubmed, doi:10.1590/S1677-5538.IBJU.2017.04.03.
Schulman AA, Polascik TJ. Most of patients with localized prostate cancer will be treated in the future? | Opinion: No. Int Braz J Urol. 2017;43(4):584–587.

Published In

Int Braz J Urol

DOI

EISSN

1677-6119

Publication Date

2017

Volume

43

Issue

4

Start / End Page

584 / 587

Location

Brazil

Related Subject Headings

  • Urology & Nephrology
  • Risk Assessment
  • Prostatic Neoplasms
  • Prostate-Specific Antigen
  • Prognosis
  • Male
  • Magnetic Resonance Imaging
  • Humans
  • Forecasting
  • Early Detection of Cancer